Alan M. Litwin
Alan M. Litwin publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #2,213,306 of 7,710,434 ranked researchers
- Rank in United States
- #663,561 of 1,627,098
- Works
- 56
- Citations
- 999
- Citations per work
- 17.8
What does Alan M. Litwin research?
Alan M. Litwin's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3867.7%
- Medicine3867.7%
- Everything else1424.8%
- Life Sciences47.5%
- 1Pulmonary and Respiratory Medicine24% of their works
- 2Oncology18% of their works
- 3Surgery13% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Molecular Biology8% of their works
- 6Hepatology5% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Histone Deacetylase Inhibitors Research
- Neuroendocrine Tumor Research Advances
Which keywords describe Alan M. Litwin's research?
The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Pancreatic Cancer, Surgical Complications, Cetuximab, CT Screening, KRAS Mutations and Lung Cancer.
- Pancreatic Neuroendocrine Tumors
- Histone Deacetylases
- Mutational Signatures
- Liver Cancer
- EGFR Mutations
- Lung Cancer
- Cetuximab
- Surgical Complications
- Targeted Therapy
- Chemotherapy
- Pancreatic Cancer
- CT Screening
- KRAS Mutations
- ALK Inhibitors
- Hepatocellular Carcinoma
- Cancer Genomics
- HDAC Inhibitors
- Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy283 topics
- Targeted Therapy142 topics
- Pancreatic Cancer101 topic
- Surgical Complications101 topic
- CT Screening91 topic
- Cetuximab91 topic
- KRAS Mutations91 topic
- Lung Cancer91 topic
- ALK Inhibitors81 topic
- EGFR Mutations81 topic
- Hepatocellular Carcinoma71 topic
- Liver Cancer71 topic
- Cancer Genomics61 topic
- Mutational Signatures61 topic
- HDAC Inhibitors51 topic
- Histone Deacetylases51 topic
- Neuroendocrine Tumors51 topic
- Pancreatic Neuroendocrine Tumors51 topic
Where does Alan M. Litwin work?
Alan M. Litwin's main affiliation in the publication record is Roswell Park Comprehensive Cancer Center, United States.
How many publications and citations does Alan M. Litwin have?
OpenAlex counts 56 works and 999 citations for Alan M. Litwin, an h-index of 16, ranking #2,213,306 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alan M. Litwin. Posts are plain text and can be reported.